Nanovehicles for co-delivery of anticancer agents

Mahdi Zeinali, Soheil Abbaspour-Ravasjani, Marjan Ghorbani, Afshin Babazadeh, Tannaz Soltanfam, Ana Cláudia Santos, Hamed Hamishehkar, Michael R. Hamblin

Research output: Contribution to journalReview articlepeer-review

64 Citations (Scopus)


Using nanovehicles for co-delivery of two or more anticancer agents shows benefits including: synergistic effects, promoting apoptosis pathways, reduction of toxicity and side effects, and overcoming multidrug resistance.

Original languageEnglish
Pages (from-to)1416-1430
Number of pages15
JournalDrug Discovery Today
Issue number8
Publication statusPublished - Aug 2020

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Nanovehicles for co-delivery of anticancer agents'. Together they form a unique fingerprint.

Cite this